https://www.selleckchem.com/pr....oducts/ethyl-3-amino
Further efforts are necessary for integration of this promising approach in prostate cancer decision-making. In the future, the emergence of artificial intelligence in urology, with an increasing use of radiomics and genomics data, may enable radiogenomics to assume a growing role in the evaluation of prostate cancer, with a noninvasive and personal approach in the field of personalized medicine. Further efforts are necessary for integration of this promising approach in prostate cancer decision-making. To